Literature DB >> 24583135

Detection of IgE binding component to infliximab in a patient with infliximab-induced anaphylaxis.

Sun Hyuk Hwang1, Hye-Soo Yoo1, Moon Kyung Yoon1, Hae-Sim Park2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24583135     DOI： 10.1016/j.anai.2014.02.001

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

Review 1.  Infliximab-Related Infusion Reactions: Systematic Review.

Authors:  Lev Lichtenstein; Yulia Ron; Shmuel Kivity; Shomron Ben-Horin; Eran Israeli; Gerald M Fraser; Iris Dotan; Yehuda Chowers; Ronit Confino-Cohen; Batia Weiss
Journal:  J Crohns Colitis       Date:  2015-06-19       Impact factor: 9.071

Review 2.  Clinical trials for authorized biosimilars in the European Union: a systematic review.

Authors:  Johanna Mielke; Bernd Jilma; Franz Koenig; Byron Jones
Journal:  Br J Clin Pharmacol       Date:  2016-09-05       Impact factor: 4.335

3.  Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab - Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera.

Authors:  Arne Homann; Niels Röckendorf; Arno Kromminga; Andreas Frey; Thomas A Platts-Mills; Uta Jappe
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.